Giedrius Gasiūnas

home / authors / giedrius-gasi-nas

Giedrius Gasiūnas, PhD, is chief scientific officer at Caszyme.

Articles

Genetic engineering, GMO and Gene manipulation, DNA gene editing, CRISPR-Cas9 gene editing tool | Image Source: © catalin -stock.adobe.com

CRISPR Gene-Editing Technology in the Development of Biopharmaceuticals

Laima Trinkūnienė;Giedrius Gasiūnas;Monika Paulė

June 9th 2025

Novel nucleases with diverse properties represent promising solutions, emphasizing their potential to overcome current limitations in genome editing and therapeutic delivery.

Latest Updated Articles

Published: October 11th 2024 | Updated: March 3rd 2025

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com

Published: June 2nd 2025 | Updated: June 9th 2025

Inspiring Developments

Published: May 12th 2025 | Updated: June 9th 2025

ASGCT 2025: Emerging Modalities for Cancer Treatments

Published: April 29th 2025 | Updated: June 9th 2025

Mastering SEC Biotherapeutic Characterization and Method Development

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777